Attain Ability® Family Left Ventricular Lead Chronic Performance Study
Attain Ability® Family Left Ventricular Lead Chronic Performance Study
Lead survivability will be summarized.
The purpose of this study is to evaluate long-term performance of the 4396 LV Lead. This evaluation is based on the number of lead-related complications occurring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the Model 4396 LV Lead. This study is conducted within Medtronic's post-market surveillance platform.
Patients who meet all of the following inclusion criteria and do not meet any of the following exclusion criteria are eligible for enrollment.
Inclusion Criteria
Exclusion Criteria
New York, New York 10032, United States
Montreal, Quebec H2W 1T8, Canada